Last Price | 0.55 | Max Price | 0.55 |
Min Price | 0.55 | 1 Year return | 0.00 |
Sector | Health Care | Subsector | Pharmaceuticals |
Contact info:Country: France
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 0 | 615,634 | 0.00 % |
2020 | 0 | 638,070 | 0.00 % |
2021 | 0 | 727,968 | 0.00 % |
2022 | 0 | 787,273 | 0.00 % |
2023 | 0 | 0 | 0.00 % |
No Records Found
No Records Found
No Records Found
The core activities of Oxis International are in the pharmaceutical sector. The past 10 years the (international) industry gained at around 75 percent. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-2016) there is a minus of 75 percent.
The French company didn't pay out any dividends (in the past 5 years).
At the end of 2015 the French company's balance sheet was worth 0 million euros. 0 million euros ( percent of the total balance sheet) was financed by debt.
All Oxis International's annual reports can be found here. More information about Oxis International can be found it's website. .
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
0
|
0
|
0
|
0
|
0
|
|
Costs |
21
|
-10
|
144
|
259
|
39
|
28
|
Profit |
-21
|
10
|
-144
|
-259
|
-39
|
-28
|
Margin of profit |
-71533.33
|
0.0
|
0.0
|
0.0
|
0.0
|
|
ROI |
42.58
|
-52.08
|
-57.24
|
-2246.01
|
201.93
|
96.72
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
-50
|
-19
|
252
|
12
|
-19
|
-29
|
Debt |
50
|
19
|
3
|
14
|
20
|
35
|
Total assets |
0
|
0
|
254
|
25
|
0
|
6
|
Solvency |
-100800.00
|
-62533.33
|
99.01
|
45.43
|
-4785.00
|
-516.96
|
Cash |
0
|
0
|
1
|
0
|
0
|
5
|
Cashflow |
-5
|
-2
|
-5
|
-11
|
-4
|
-7
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
-0.09
|
-0.10
|
-2.16
|
-0.77
|
-0.19
|
-0.21
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
792.00
|
48.00
|
4.50
|
1.03
|
1.03
|
Eps |
2038.62
|
-146.17
|
-87.71
|
-11.42
|
-6.45
|
Price/earnings-ratio |
0.39
|
-0.33
|
-0.05
|
-0.09
|
-0.09
|
Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
Book value |
-3065.36
|
85.44
|
3.87
|
-4.66
|
-5.61
|
Market to book |
-3.87
|
1.78
|
0.86
|
-4.53
|
-10.20
|
Cashflow per stock |
-315.36
|
-1.84
|
-3.58
|
-0.89
|
-1.39
|
Stocks |
0
|
3
|
3
|
4
|
5
|
Market Cap |
4.85
|
141.50
|
13.41
|
4.23
|
2.87
|
Date
|
Price
|
---|---|
18 Apr 2024
|
0.55
|
17 Apr 2024
|
0.55
|
09 Apr 2024
|
0.55
|
05 Apr 2024
|
0.55
|
03 Apr 2024
|
0.55
|
30 Mar 2024
|
0.55
|
22 Mar 2024
|
0.55
|
18 Mar 2024
|
0.55
|
15 Mar 2024
|
0.55
|
12 Mar 2024
|
0.55
|
11 Mar 2024
|
0.55
|
09 Mar 2024
|
0.55
|
07 Mar 2024
|
0.55
|
01 Mar 2024
|
0.55
|
29 Feb 2024
|
0.55
|
27 Feb 2024
|
0.55
|
22 Feb 2024
|
0.55
|
21 Feb 2024
|
0.55
|
20 Feb 2024
|
0.55
|
15 Feb 2024
|
0.55
|
14 Feb 2024
|
0.55
|
13 Feb 2024
|
0.55
|
09 Feb 2024
|
0.55
|
08 Feb 2024
|
0.55
|
07 Feb 2024
|
0.55
|
06 Feb 2024
|
0.55
|
05 Feb 2024
|
0.55
|
01 Feb 2024
|
0.55
|
31 Jan 2024
|
0.55
|
30 Jan 2024
|
0.55
|